CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL P08648-1 GLY 000040 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

ITA5 HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites unicarbkb.csv

File (Entity type)
Description:Information for protein P08648-1 in the context of file GLY_000040
Creation Time:2026-03-02 19:56:34.000000
Results found

Linked to

 

Label

Description

 

Compound

G45495MK

Compound (Entity type)

type="Saccharide" mass="2077.74549812" permass="2582.30890064" monosaccharides="11" is_motif="False"...

Compound

G57818FI

Compound (Entity type)

type="Saccharide" mass="1786.65008149" permass="2221.13523366" monosaccharides="10" is_motif="False"...

Protein

ITA5 HUMAN

Protein (Entity type)

Integrin alpha-5

Compound

G61627IG

Compound (Entity type)

type="Saccharide" mass="1989.7294541" permass="2466.26155647" monosaccharides="11" is_motif="False" ...

Post Translational Modification

p08648-1 868asn 868asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p08648-1 900ser 910lys range go:0006486

Post Translational Modification (Entity type)

A Post Translational Modification

Compound

G25703UN

Compound (Entity type)

type="Saccharide" mass="1932.70799036" permass="2395.22444267" monosaccharides="11" is_motif="False"...

Compound

G12604EW

Compound (Entity type)

type="Saccharide" mass="1989.7294541" permass="2466.26155647" monosaccharides="11" is_motif="False" ...

  • Compound

    G45495MK

    Compound (Entity type)

    type="Saccharide" mass="2077.74549812" permass="2582.30890064" monosaccharides="11" is_motif="False"...

  • Compound

    G57818FI

    Compound (Entity type)

    type="Saccharide" mass="1786.65008149" permass="2221.13523366" monosaccharides="10" is_motif="False"...

  • Protein

    ITA5 HUMAN

    Protein (Entity type)

    Integrin alpha-5

  • Compound

    G61627IG

    Compound (Entity type)

    type="Saccharide" mass="1989.7294541" permass="2466.26155647" monosaccharides="11" is_motif="False" ...

  • Post Translational Modification

    p08648-1 868asn 868asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    p08648-1 900ser 910lys range go:0006486

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Compound

    G25703UN

    Compound (Entity type)

    type="Saccharide" mass="1932.70799036" permass="2395.22444267" monosaccharides="11" is_motif="False"...

  • Compound

    G12604EW

    Compound (Entity type)

    type="Saccharide" mass="1989.7294541" permass="2466.26155647" monosaccharides="11" is_motif="False" ...

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.